{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-026947","form_type":"8-K","ticker":null,"cik":"0001537561","company_name":"Arch Therapeutics, Inc.","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.242085+00:00","generated_at":"2026-06-10T08:10:40.542032+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arch Therapeutics increases authorized common stock from 12M to 350M, creates 5M blank check preferred","bullets":["Authorized common shares increased from 12,000,000 to 350,000,000, par value $0.001.","Authorized 5,000,000 shares of blank check preferred stock, par value $0.001.","Amendment approved by board on July 18, 2023 and stockholders on August 22, 2023; effective September 21, 2023.","No immediate purpose for the additional shares was disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-026947","json":"https://secwatch.observer/filing/0001437749-23-026947.json","markdown":"https://secwatch.observer/filing/0001437749-23-026947.md","text":"https://secwatch.observer/filing/0001437749-23-026947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1537561/000143774923026947/0001437749-23-026947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1537561/000143774923026947/arch20230927_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:10:40.542032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a3a31eb598bc0d41ab3c215f48eec700743a06d3","claim":"Arch Therapeutics, Inc.: Increased authorized common shares from 12,000,000 to 350,000,000 and authorized 5,000,000 blank-check preferred shares (effective 2023-09-21).","evidence_excerpt":"On September 21, 2023, the Company amended its Articles of Incorporation by filing a Certificate of Amendment (the “Certificate of Amendment”) with the Secretary of State of Nevada to increase the total number of authorized shares of common stock, par value $0.001 per share, from 12,000,000 to 350,000,000, and to authorize 5,000,000 shares of “blank check” preferred stock, par value $0.001 per share.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1537561/000143774923026947/0001437749-23-026947-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-09-21"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}